Related Experiment Video
Updated: Aug 9, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
New vaccines for the prevention of pneumococcal infections
1Department of Vaccines, National Public Health Institute, Helsinki, Finland. helena.kayhty@ktl.fi
Insights
Vaccination against Streptococcus pneumoniae is crucial due to rising antibiotic resistance. New conjugate vaccines show promise in improving immunogenicity and efficacy against pneumococcal infections, especially in vulnerable populations.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Streptococcus pneumoniae causes severe infections like pneumonia and meningitis.
- Emerging antibiotic-resistant strains necessitate improved vaccination strategies.
- Current vaccines are ineffective in young children and immunocompromised individuals.
Purpose of the Study:
- To address the urgent need for effective vaccines against Streptococcus pneumoniae.
- To evaluate the potential of novel pneumococcal vaccine candidates.
- To investigate the efficacy of pneumococcal conjugate vaccines.
Main Methods:
- Clinical trials of first-generation pneumococcal conjugate vaccines.
- Covalent coupling of pneumococcal capsular polysaccharides to protein carriers.
- Studying the protective efficacy against pneumococcal carriage and invasive infections.
Main Results:
- Pneumococcal conjugate vaccines improve polysaccharide immunogenicity.
- Efficacy against carriage, acute otitis media, and invasive infections is under investigation.
- Development of more effective vaccines against Streptococcus pneumoniae is ongoing.
Conclusions:
- Pneumococcal conjugate vaccines represent a significant advancement in preventing pneumococcal diseases.
- Further research is essential to optimize vaccine efficacy and broaden protection.
- Vaccination remains a key strategy to combat pneumococcal infections and antibiotic resistance.
Abstract:
Streptococcus pneumoniae is a major cause of acute otitis media, pneumonia, bacteremia, and meningitis. Because in recent years antibiotic-resistant pneumococcal strains have been emerging throughout the world, vaccination against pneumococcal infections has become more urgent. The capsular polysaccharide vaccine that has been available is neither immunogenic nor protective in young children and other immunocompromised patients. Several pneumococcal proteins have been proposed as candidate vaccines, but no human studies associated with them have been reported. Clinical trials of first-generation pneumococcal conjugate vaccines have shown that covalent coupling of pneumococcal capsular polysaccharides to protein carriers improves the immunogenicity of the polysaccharides. The protective efficacy of the conjugate vaccines against carriage, acute otitis media, and invasive infections is being studied.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Vaccines
Streptococcal Pharyngitis
Respiratory Syncytial Virus Disease